EFFICACY AND SAFETY OF SAXAGLIPTIN IN COMBINATION WITH INSULIN IN PATIENTS WITH LONG-STANDING TYPE 2 DIABETES

被引：0
|
作者：
Iqbal, Nayyar [4 ]
Minervini, Gianmaria [1 ]
Charbonnel, Bernard [2 ]
Barnett, Anthony [3 ]
Monyak, John [1 ]
机构：
[1] AstraZeneca, Wilmington, DE USA
[2] Ctr Hosp Univ Nantes, Nantes, France
[3] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
INTERNAL MEDICINE JOURNAL | 2013年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of saxagliptin (SAXA) in patients with type 2 diabetes and a history of cardiovascular disease
    Cook, W.
    Bryzinski, B.
    Slater, J.
    Donovan, M.
    Allen, E.
    DIABETOLOGIA, 2012, 55 : S346 - S346
  • [22] Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy
    Bryzinski, Brian
    Allen, Elsie
    Cook, William
    Hirshberg, Boaz
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 887 - 893
  • [23] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH EARLY AND LONG-STANDING RHEUMATOID ARTHRITIS
    Kanonirova, M. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A85 - A86
  • [24] Etiologies underlying subtypes of long-standing type 2 diabetes
    Bayoumi, R.
    Farooqi, M. H.
    Alawadi, F.
    Hassanein, M.
    Osama, A.
    Mukhopadhyay, D.
    Abdul, F.
    Sulaiman, F.
    Dsouza, S.
    Mulla, F.
    Ahmed, F. S.
    Alsharhan, M.
    Khamis, A. H.
    CLINICA CHIMICA ACTA, 2024, 558
  • [25] Etiologies underlying subtypes of long-standing type 2 diabetes
    Bayoumi, Riad
    Farooqi, Muhammad
    Alawadi, Fatheya
    Hassanein, Mohamed
    Osama, Aya
    Mukhopadhyay, Debasmita
    Abdul, Fatima
    Sulaiman, Fatima
    Dsouza, Stafny
    Mulla, Fahad
    Ahmed, Fayha
    AlSharhan, Mouza
    Khamis, Amar
    PLOS ONE, 2024, 19 (05):
  • [26] Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
    Jain, Rajeev
    ADVANCES IN THERAPY, 2015, 32 (11) : 1065 - 1084
  • [27] Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
    Rajeev Jain
    Advances in Therapy, 2015, 32 : 1065 - 1084
  • [28] Long-termefficacy and safety of canagliflozin in combination with insulin in Japanese type 2 diabetes patients
    Harashima, S.
    Inagaki, N.
    Kaku, K.
    Kondo, K.
    Maruyama, N.
    Otsuka, M.
    Kawaguchi, Y.
    Watanabe, Y.
    Goda, M.
    Iijima, H.
    DIABETOLOGIA, 2017, 60 : S20 - S20
  • [29] Epicardial adipose tissue as a marker of insulin resistance in patients with long-standing type 1 diabetes mellitus
    Moustafa, A.
    Vilades, D.
    Colom Comi, C.
    Perez-Perez, A.
    Carreras, F.
    Leta, R.
    Pons, G.
    EUROPEAN HEART JOURNAL, 2015, 36 : 117 - 118
  • [30] Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis
    Men, Peng
    Li, Xiao-tong
    Tang, Hui-lin
    Zhai, Suo-di
    PLOS ONE, 2018, 13 (05):
12345